top of page

Board of Directors

Headshot.jpg

DAN ADAMS, JD

Chairman, EpiVax Therapeutics

ADG - Headshot.jpg

ANNE (ANNIE) DE GROOT, MD

Co-Founder, CEO & CSO @ EpiVax

Bill_edited.jpg

WILLIAM MARTIN, BA

Co-Founder, COO & CIO @ EpiVax

RL headshot_edited.png

RICHARD LIPKIN, MBA

Managing Director @ Easton Capital
Co-founder of The Catalytic Impact Foundation

Rachel-Butler_200x200.png

RACHEL BUTLER
President @ The Catalytic Impact Foundation

ADVISORS

bridon.jpg

DOMINIQUE BRIDON, PHD

CEO, Diaccurate

 

Peptide technology expert with over 35 years of experience

M. Cox.jpg

MANON COX, PHD, MBA

CEO, NextWaveBio

Scientific and strategic direction

Amy-Rosenberg_edited.jpg

AMY ROSENBERG, MD

Senior Director, EpiVax
Former Division Director, CDER, FDA

Regulatory veteran

J.Lieberman.webp

JUDY LIEBERMAN, MD, PHD

Professor & Chair Immunology, Harvard Medical School

Accomplished immunology expert

E.Ramos.jpg

ELENAOR RAMOS, MD

CMO/COO, Provention Bio

Clinical development and medical affairs specialist

Chemistry Class

PARTNERS

NYU-Langone.jpg

NYU LANGONE HEALTH

U.Chicago.png

UNIVERSITY OF CHICAGO

MountSinai_IcahnSchool_Logo.jpg

MOUNT SINAI

SGI.jpg

SYNTHETIC GENOMICS

Brown.jfif

BROWN UNIVERSITY

ITI.png

IMMUNOMIC THERAPEUTICS

Polypeptide.jpg

POLYPEPTIDE GROUP

21stCentury.jfif

21ST CENTURY

Image by Mikita Yo

INVESTORS

Morningside-Main-logo-002.jpg

MORNINGSIDE VENTURES

paa_logo4x3.jpg

PRINCETON ALUMNI ANGELS

CatalyticImpactFoundation_logo.jpg

CATALYTIC IMPACT FOUNDATION

Next Wave Bio.png

NEXT WAVE BIO

ANY Seed Fund.png

ACCELERATE NEW YORK SEED FUND

bottom of page